AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Cytovance Biologics selects Sartorius BBI Systems bioreactors for its Oklahoma city biopharmaceutical manufacturing facility; completion of cGMP facility validation anticipated in summer 2006.

Chemical Business Newsbase

| November 22, 2005 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Press Release)

Cytovance Biologics has selected Sartorius BBI Systems Inc to supply bioreactors for its cGMP biopharmaceutical production facility in Oklahoma City, OK. Cytovance Biologics will install two Biostat DC industrial bioreactor systems in support of its contract biopharmaceutical process development and manufacturing business. The Biostat D-100C (100 l working volume) and Biostat D-500C (500 l working volume) systems will be located in dedicated cell culture production suites within Cytovance's 44,000 sq ft cGMP production facility located on the Presbyterian Health Foundation Research Park. Installation of the systems is …

Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily